Grænseoverskridende konverter
NACE Rev 2.1 21.10 → SBI 2025-modstykke (Netherlands)
Cypruss nationale aktivitetsklassifikation (NACE Rev 2.1) deler sin 4-cifrede rygrad med EU NACE Rev 2.1-standarden. På den baggrund viser vi den eller de ækvivalente SBI 2025-underklasse(r), der bruges i Netherlands.
Fælles EU-overklasse
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21.10
Manufacture of basic pharmaceutical products
21100
Manufacture of basic pharmaceutical products
Om denne konvertering
NACE Rev 2.1 er aktivitetsklassifikationen, der bruges i Cyprus. SBI 2025 er det ækvivalente system i Netherlands. Begge er nationale implementeringer af EU NACE Rev 2.1, så enhver 5-cifret underklasse i ét system kan spores tilbage til en fælles 4-cifret EU-klasse — og derfra videre ind i det andet lands underklasser.
Denne side er genereret for forespørgslen „NACE Rev 2.1 21.10 til SBI 2025“ og holdes synkroniseret med vores månedlige Market Intelligence-synkronisering.